Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy.

Saved in:

Bibliographic Details
Title:	Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy.
Authors:	Smyth P; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom., Ferguson L; Elasmogen Ltd., Aberdeen, United Kingdom., Burrows JF; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom., Burden RE; School of Pharmacy, Queen's University Belfast, Belfast, United Kingdom., Tracey SR; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom., Herron ÚM; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom., Kovaleva M; Elasmogen Ltd., Aberdeen, United Kingdom., Williams R; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom., Porter AJ; Elasmogen Ltd., Aberdeen, United Kingdom.; Scottish Biologics Facility, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom., Longley DB; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom., Barelle CJ; Elasmogen Ltd., Aberdeen, United Kingdom., Scott CJ; Patrick G. Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, United Kingdom.
Source:	Frontiers in pharmacology [Front Pharmacol] 2023 Dec 05; Vol. 14, pp. 1296567. Date of Electronic Publication: 2023 Dec 05 (Print Publication: 2023).
Publication Type:	Journal Article
Journal Info:	Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1663-9812
DOI:	10.3389/fphar.2023.1296567